Central Garden & Pet Q2 sales rise 8.6%, beat estimates
Central Garden & Pet Company CENT | 0.00 |
Overview
US pet and garden goods firm's preliminary fiscal Q2 sales rose, beating analyst expectations
Preliminary operating income for fiscal Q2 beat analyst expectations
Company reaffirmed fiscal 2026 non-GAAP EPS outlook and announced new pet distribution partnership
Outlook
Central Garden & Pet maintains fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better
Company expects pet distribution partnership to have minimal impact on fiscal 2026 EPS
Capital expenditures projected at $50 mln to $60 mln for fiscal 2026
Result Drivers
PET SEGMENT GROWTH - Co said Pet segment sales rose due to continued strength in Dog & Cat and Animal Health, and Outdoor Cushions shipment timing
GARDEN SEGMENT GROWTH - Co said Garden segment sales rose due to shipment timing and new listings in Grass and Fertilizer
MARGIN EXPANSION - Co reported expanded gross and operating margins, citing consistent execution and improving performance across the organization
Company press release: ID:nBw9nfN1Na
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 Sales |
Beat |
$906 mln |
$844.70 mln (5 Analysts) |
Q2 EPS |
|
$1.28 |
|
Q2 Net Income |
|
$79 mln |
|
Q2 Operating Income |
Beat |
$114 mln |
$99.05 mln (4 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the food processing peer group is "buy"
Wall Street's median 12-month price target for Central Garden & Pet Co is $50.00, about 38.5% above its May 5 closing price of $36.09
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 12 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
